Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033839
Status:
COMPLETED
Last Update Posted:
2011-06-10
First Post:
2002-04-11
Brief Title:
A Phase III Study of Civamide Nasal Solution Zucapsaicin for the Treatment of Episodic Cluster Headache
Sponsor:
Winston Laboratories
Organization:
Winston Laboratories
Study Overview
Official Title:
A Phase III Double-Blind Randomized Placebo-Controlled Parallel-Group Multicenter Evaluation of Civamide Zucapsaicin Nasal Solution in the Treatment of Episodic Cluster Headache
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide Zucapsaicin in the treatment of an episodic cluster headache period compared to placebo medically inactive substance which does not contain any active ingredients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None